Pulse Biosciences (PLSE) Total Liabilities (2015 - 2025)

Pulse Biosciences' Total Liabilities history runs 11 years deep, the most recent figure standing at $13.9 million for Q4 2025.

• On a quarterly basis, Total Liabilities fell 21.11% year-over-year to $13.9 million in Q4 2025; TTM through Dec 2025 was $13.9 million, a 21.11% decrease from a year earlier, with the FY2025 full-year figure at $13.9 million, down 21.11% from the prior year.
• Total Liabilities retreated to $13.9 million in Q4 2025 per PLSE's latest filing, from $16.1 million in the prior quarter.
• Across five years, Total Liabilities topped out at $81.4 million in Q3 2022 and bottomed at $12.9 million in Q1 2024.
• The 5-year median for Total Liabilities is $15.9 million (2025), against an average of $27.7 million.
• Across the five-year window, Total Liabilities jumped 497.24% in 2021 and tumbled 84.08% in 2024, its largest moves.
• Year by year, Total Liabilities stood at $14.8 million in 2021, then jumped by 441.6% to $80.1 million in 2022, then plunged by 81.54% to $14.8 million in 2023, then gained by 18.95% to $17.6 million in 2024, then retreated by 21.11% to $13.9 million in 2025.
• Per Business Quant, the three latest PLSE Total Liabilities figures stand at $13.9 million (Q4 2025), $16.1 million (Q3 2025), and $15.8 million (Q2 2025).